Announcements Trials

Browse Landscape Eligibility

Clinical Trials

0 trials

Recent Start date Enrollment

Carcinoma, Ovarian Epithelial × Albumin-Bound Paclitaxel × 1 year × Clear all

Sponsor

Conditions

Pancreatic Neoplasms 40 Triple Negative Breast Neoplasms 17 Breast Neoplasms 16 Carcinoma, Non-Small-Cell Lung 13 Squamous Cell Carcinoma of Head and Neck 9 Parkinson Disease 4, Autosomal Dominant Lewy Body 6 Neoplasm Metastasis 6 Lung Neoplasms 6 Esophageal Neoplasms 6 Stomach Neoplasms 5 Ovarian Neoplasms 4 Esophageal Squamous Cell Carcinoma 4 Cholangiocarcinoma 4 Gallbladder Neoplasms 3 Fallopian Tube Neoplasms 3 Endometrial Neoplasms 3 Colorectal Neoplasms 3 Adenocarcinoma 3 Uterine Cervical Neoplasms 2 Urinary Bladder Neoplasms 2 Recurrence 2 Rectal Neoplasms 2 Pancreatic Adenocarcinoma 2 Colonic Neoplasms 2 Carcinoma, Pancreatic Ductal 2 Carcinoma, Hepatocellular 2 Carcinoma 2 Biliary Tract Neoplasms 2 Thyroid Neoplasms 1 Thyroid Carcinoma, Anaplastic 1

Interventions

Paclitaxel 12 Carboplatin 8 pembrolizumab 7 Bevacizumab 7 liposomal doxorubicin 5 Nivolumab 5 mirvetuximab soravtansine 4 Topotecan 4 ribociclib 3 olaparib 3 Fulvestrant 3 Drug Therapy 3 rucaparib 2 pegfilgrastim 2 palbociclib 2 oregovomab 2 niraparib 2 fludarabine phosphate 2 fludarabine 2 Irinotecan 2 Hyperthermic Intraperitoneal Chemotherapy 2 Gemcitabine 2 Cyclophosphamide 2 Blood Specimen Collection 2 1-dodecylpyridoxal 2 trastuzumab deruxtecan 1 spartalizumab 1 sargramostim 1 sacituzumab govitecan 1 isoquercitrin 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

No trials found.

Data powered by HemOnc (CC BY 4.0) Colophon ⚡